drugset / Trial / NCT07074236
Pharmacokinetics and Pharmacodynamics Study
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare the pharmacokinetics and pharmacodynamics behavior of the two formulation of QLC7401 injection to further evaluate the effect of the production site change.
Timeline
- Start
- 2025-07
- Primary completion
- 2026-01
- Completion
- 2026-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | QLC7401 | Small interfering RNA (siRNA) | — | — |
| Subject | RBD7022 | Unknown | — | — |